Explore more Categories
Artificial Intelligence involves the science and engineering of developing intelligent machines
The manufacturing world is at a cusp of a new revolution that will redefine conventional business models
IoT will have a major impact on businesses and consumers in the future
The world is creating 2.5 exabytes of data daily
Our research seeks to connect-the-dots across multiple trends
Personal Robots are Set to Be a $19 Billion Market
Strategic Analysis of BREXIT and its Implications to Industries, Economies and Societies
Time for a Digital Revolution in the Women’s Health Market
iFrost is a digital platform for interactive and dynamic reporting of data.
The TOEs are a great source of information which gives corporates critical information on companies to action for their strategic investments either as an open source platform or to collaborate and to develop successful products
Upcoming Product Launches in Adoptive Cell Therapy Segment Hold Future Growth Potential
* Required Fields
Pay by invoice
This study explores the global immuno-oncology (I-O) market’s evolution from 2020 to 2025. An extensive analysis is provided on the growth opportunities envisioned by Frost & Sullivan to help stakeholders leverage their momentum and disrupt the market by offering best-in-class solutions.The study considers oncology agents for which the immune system is the basis of their actions, including monoclonal antibodies, cell and gene therapies, bioengineered vaccines, recombinant products, small molecules, and oncolytic viruses. Classified into 5 major therapy types—immunomodulators, adoptive cell therapy, cancer vaccine, oncolytic virus, and antibody-based targeted therapies—the analysis provides revenue forecasts by global market and product category. The agents are classified into various therapy types based on the mechanism of action (MOA). Concerning pipeline products, we have considered industry-sponsored products under development.The oncology therapeutic segment is expected to witness minimal impact from the COVID-19 pandemic because of the criticality of treating cancer patients and the segment’s role as a major revenue-generator for pharmaceutical companies. Frost & Sullivan have considered the impact of COVID-19 and two scenarios for the sales forecast: original scenario and COVID-19 impact scenario.In the original scenario, the I-O market is expected to reach $132.66 billion by 2025 growing at a rate of 11.6% and witness minimal impact from the COVID-19 pandemic, with 2020 accounting for the majority of decline. After 2022, the market will positively recuperate and experience a slight increase in revenue due to rebounding R&D budgets and accelerated developments of late-stage clinical candidates.
Major Themes Covered in This Study:
Author: Cecilia VanCauwenberghe
Regulatory and Infrastructure Reforms in India and China Catalyzing the Asian Specialty Generics Market
Antimicrobial Technologies for Enhanced Consumer Health
Growth Opportunities in the Global Cell Therapy Market, Forecast to 2025
Growth Opportunities in the Neurodegenerative Disorder Therapeutics Market, Forecast to 2024
Growth Opportunities in the Global Pharmaceutical Contract Manufacturing Organization Market (CMO), Forecast to 2024
Emerging Microbiome Technologies for Applications in Skin Care
Anti-Aging Therapies and Services Market—Trends and Growth Opportunities, Forecast to 2022
Cardiometabolic Diseases Market—Trends and Growth Opportunities, Forecast to 2022
Mergers and Acquisitions in the Global Life Sciences Industry, 2018
Global Cell Therapy Market—Companies to Action, 2018
health supplement market
packaged food industry
commercial aircraft market forecast
food waste market
solar energy market
plastic recycling market
functional beverage market
Don't have an account? Create One!
Enter your Email Address here to receive a link to change password.
If you are an existing frost.com user, please register using the same email for seamless access
Already have an account? Login!
Use your Linkedin account to login or register within our store.You're just one click away.